SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
May 2, 2019
Document Date
Nov 26, 2018
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Filer
SMITH DAVID V